+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Foot & Mouth Disease Vaccines Market - Global Forecast 2026-2032- Product Image
Foot & Mouth Disease Vaccines Market - Global Forecast 2026-2032- Product Image
Sale

Foot & Mouth Disease Vaccines Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 4829815
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Foot & Mouth Disease Vaccines Market is projected to reach USD 3.49 Billion in 2026. It is expected to continue growing at a CAGR of 9.38%, reaching USD 6.01 Billion by 2032.

Foot and mouth disease vaccines remain central to livestock biosecurity because FMD is a highly contagious transboundary animal disease affecting cattle, pigs, sheep, goats, buffalo, and susceptible wildlife. According to WOAH and FAO guidance, vaccination is most effective when paired with surveillance, movement control, rapid diagnostics, and strong veterinary governance.

The market is shaped by seven immunologically distinct FMD virus serotypes, regional strain diversity, and the need for antigenically matched vaccines. Demand is strongest where endemic risk, cattle density, export protection, and government-led immunization programs converge, particularly in regions where livestock production is closely linked to food security, rural livelihoods, and access to international trade.

Transformative Shifts in the FMD Vaccine Landscape

The FMD vaccines landscape is shifting from reactive outbreak response toward prevention-led disease control. Governments are expanding vaccine banks, strengthening cold-chain readiness, and aligning national programs with WOAH-recognized FMD control pathways to protect meat, dairy, and live-animal trade.

Manufacturers are competing on high-potency formulations, purified inactivated vaccines, multivalent coverage, and validated quality systems. At the same time, DIVA-compatible strategies, improved diagnostics, and molecular epidemiology are making vaccine selection more evidence-driven and region-specific, helping veterinary authorities connect field surveillance with targeted vaccination policies.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is improving how FMD vaccine decisions are made by connecting genomic surveillance, outbreak reports, animal movement data, climate-linked risk indicators, and vaccine inventory signals. AI-supported analytics can help identify circulating lineages, prioritize antigen matching, and model where emergency vaccination would reduce spread most efficiently.

In manufacturing and distribution, AI can support batch consistency monitoring, demand planning, cold-chain risk detection, and procurement coordination. Its value depends on validated datasets, veterinary oversight, and responsible integration with laboratory-confirmed epidemiology rather than replacing expert judgment.

Key Regional Insights

Asia-Pacific represents a major demand center because China, India, and parts of Southeast Asia combine large livestock populations with persistent FMD risk, while Australia and Japan maintain strict freedom programs through border biosecurity, surveillance, and emergency preparedness. North America is largely FMD-free and focuses on preparedness, vaccine banks, diagnostic readiness, surveillance, and rapid response capacity to protect livestock production and trade continuity.

Latin America continues to advance FMD-free recognition and export protection, with Brazil playing a pivotal role in cattle-sector disease policy and progressive vaccination-to-surveillance transitions in recognized zones. Europe emphasizes non-routine vaccination, rapid detection, movement controls, and contingency planning under harmonized animal-health frameworks. The Middle East faces import-related and transboundary risk due to livestock movement and regional trade flows, while Africa remains strategically important because multiple FMD serotypes circulate across pastoral, smallholder, and cross-border livestock systems, making antigen matching and coordinated vaccination essential.

Key Group Insights

ASEAN markets are shaped by cross-border animal movement, smallholder livestock systems, and coordinated disease-control needs, especially where cattle, buffalo, and pig production intersect with informal trade routes. The GCC emphasizes import security, veterinary surveillance, quarantine capacity, and contingency access to vaccines to reduce exposure from animal and animal-product movements. The European Union sets a high regulatory benchmark through harmonized animal-health law, laboratory networks, diagnostic capacity, traceability, and emergency preparedness.

BRICS countries are influential because they include major livestock producers, large vaccination programs, expanding animal-health manufacturing capabilities, and significant exposure to food security and trade-protection priorities. G7 countries drive innovation, funding, reference-laboratory collaboration, and biosecurity standards, while NATO members increasingly treat animal disease preparedness as part of broader resilience for food supply chains, civil protection, and critical infrastructure continuity.

Key Country Insights

The United States and Canada remain focused on FMD freedom, vaccine-bank access, diagnostic readiness, simulation exercises, and emergency response planning, while Mexico maintains FMD-free status through border controls, surveillance, and coordinated animal-health safeguards. Brazil is central to Latin American progress, supported by decades of coordinated vaccination, surveillance policy, zoning, and export-oriented disease-control governance.

In Europe, the United Kingdom, Germany, France, Italy, and Spain rely on EU-aligned or comparable controls, rapid diagnostics, traceability, movement restrictions, and contingency vaccination rather than routine use. Russia manages risk across diverse livestock zones and long land borders. China and India sustain large-scale immunization needs due to livestock density and endemic exposure, Japan and Australia prioritize exclusion through strict biosecurity and emergency preparedness, and South Korea combines surveillance with vaccination informed by prior outbreak experience and intensive livestock production systems.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize antigen matching, regional strain intelligence, and partnerships with national veterinary authorities. Investment in validated multivalent vaccines, high-potency emergency products, secure antigen reserves, and reliable cold-chain systems will be critical for both endemic control and outbreak preparedness.

Organizations should also strengthen pharmacovigilance, DIVA-aligned testing support, field effectiveness monitoring, and transparent quality documentation. Commercial strategies should reflect public procurement cycles, export-market disease requirements, regulatory expectations, and the practical realities of vaccine delivery across smallholder, intensive, and transboundary livestock systems.

Research Methodology

Research methodology is built from verified secondary research, including WOAH and FAO disease-control guidance, national veterinary authority publications, peer-reviewed scientific literature, reference-laboratory updates, and publicly available policy documents on FMD surveillance, vaccination, diagnostics, and emergency preparedness.

The analysis emphasizes triangulation across epidemiology, regulatory frameworks, procurement behavior, livestock demographics, serotype and lineage circulation, vaccine technology trends, and trade-related animal-health requirements. Market interpretation excludes unsupported revenue claims and focuses on evidence-backed drivers such as disease status, vaccination policy, biosecurity readiness, antigenic matching, and trade-protection incentives.

Conclusion

Foot and mouth disease vaccines are essential tools for protecting livestock health, food security, rural economies, and international animal-product trade. Their effectiveness depends on matching vaccines to circulating strains, maintaining quality-assured supply, and embedding immunization within broader surveillance, diagnostics, movement control, and biosecurity systems.

The strongest opportunities will emerge for manufacturers and public-sector partners that combine scientific credibility, regional preparedness, digital intelligence, regulatory alignment, and dependable field execution. As FMD risk remains uneven across regions, the market will continue to reward evidence-based, adaptable, and policy-aligned vaccine strategies.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Foot & Mouth Disease Vaccines Market, by Vaccine Type
7.1. Introduction
7.2. Conventional Vaccines
7.2.1. Inactivated (Killed) Vaccines
7.2.2. Oil-Based Vaccines
7.2.3. Aluminum Hydroxide/Saponin-Based Vaccines
7.3. Modified / Attenuated Live Vaccines
7.4. Recombinant Vaccines
7.5. Emergency Vaccines
8. Foot & Mouth Disease Vaccines Market, by Animal Type
8.1. Introduction
8.2. Cattle
8.3. Swine
8.4. Sheep & goats
9. Foot & Mouth Disease Vaccines Market, by Route Of Administration
9.1. Introduction
9.2. Injection
9.3. Oral
10. Foot & Mouth Disease Vaccines Market, by Application
10.1. Introduction
10.2. Preventive
10.3. Therapeutic
11. Foot & Mouth Disease Vaccines Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.2.1. Department Stores
11.2.2. Direct Sales
11.2.3. Specialty Stores
11.3. Online
11.3.1. Company Websites
11.3.2. E-commerce Platforms
12. Foot & Mouth Disease Vaccines Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Hospitals
12.4. Research Institutes
13. Foot & Mouth Disease Vaccines Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Foot & Mouth Disease Vaccines Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Foot & Mouth Disease Vaccines Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Agrovet Market Animal Health S.A.
17.2. Bayer AG
17.3. BIGVET Biotech Co., Ltd.
17.4. Biogénesis Bagó S.A.
17.5. Biovet Private Limited
17.6. Boehringer Ingelheim International GmbH
17.7. Botswana Vaccine Institute
17.8. Brilliant Bio Pharma Limited
17.9. Cavet Bio Co., Ltd.
17.10. Ceva Santé Animale S.A.
17.11. China Animal Husbandry Industry Co., Ltd.
17.12. Godrej Agrovet Limited
17.13. Hester Biosciences Limited
17.14. Indian Immunologicals Limited
17.15. Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
17.16. Inovet BV
17.17. Intervac Pvt. Ltd.
17.18. Jinyu Bio-Technology Co., Ltd.
17.19. Limor de Colombia S.A.
17.20. Merck & Co., Inc.
17.21. Middle East Vaccines Company
17.22. Phibro Animal Health Corporation
17.23. Selevac Pty Ltd
17.24. Shen Lian Biotechnology Co., Ltd.
17.25. Tecon Biology Co., Ltd.
17.26. VECOL S.A.
17.27. VETAL Animal Health Products Inc.
17.28. Zoetis Inc.
18. Key Experts
List of Figures
FIGURE 1. Global Foot & Mouth Disease Vaccines Market, Years Considered for the Study
FIGURE 2. Global Foot & Mouth Disease Vaccines Market, Research Design
FIGURE 3. Global Foot & Mouth Disease Vaccines Market, Research Framework
FIGURE 4. Global Foot & Mouth Disease Vaccines Market, Data Triangulation
FIGURE 5. Global Foot & Mouth Disease Vaccines Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2025 vs 2032 (%)
FIGURE 7. Global Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2025 vs 2032 (%)
FIGURE 9. Global Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 11. Global Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Foot & Mouth Disease Vaccines Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Foot & Mouth Disease Vaccines Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Foot & Mouth Disease Vaccines Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Foot & Mouth Disease Vaccines Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Foot & Mouth Disease Vaccines Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Foot & Mouth Disease Vaccines Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Foot & Mouth Disease Vaccines Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Foot & Mouth Disease Vaccines Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Foot & Mouth Disease Vaccines Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Foot & Mouth Disease Vaccines Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Foot & Mouth Disease Vaccines Market Segmentation & Coverage
TABLE 2. Global Foot & Mouth Disease Vaccines Market Size, 2017-2032 (USD Million)
TABLE 3. Global Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 4. Global Conventional Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Conventional Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Conventional Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Inactivated (Killed) Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Inactivated (Killed) Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Inactivated (Killed) Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Oil-Based Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Oil-Based Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Oil-Based Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Aluminum Hydroxide/Saponin-Based Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Aluminum Hydroxide/Saponin-Based Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Aluminum Hydroxide/Saponin-Based Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Modified / Attenuated Live Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Modified / Attenuated Live Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Modified / Attenuated Live Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Recombinant Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Recombinant Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Recombinant Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Emergency Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Emergency Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Emergency Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 26. Global Cattle Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Cattle Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Cattle Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Swine Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Swine Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Swine Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Sheep & goats Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Sheep & goats Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Sheep & goats Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 36. Global Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 43. Global Preventive Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Preventive Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Preventive Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Therapeutic Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Therapeutic Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Therapeutic Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 50. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Department Stores Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Department Stores Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Department Stores Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Specialty Stores Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Specialty Stores Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Specialty Stores Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Company Websites Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Company Websites Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Company Websites Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global E-commerce Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global E-commerce Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global E-commerce Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 72. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Foot & Mouth Disease Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Foot & Mouth Disease Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. North America Foot & Mouth Disease Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. North America Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 94. North America Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 95. North America Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 96. North America Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 97. North America Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. North America Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 99. North America Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 100. North America Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 101. North America Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. Latin America Foot & Mouth Disease Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Latin America Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 104. Latin America Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 105. Latin America Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 106. Latin America Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 107. Latin America Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. Latin America Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 109. Latin America Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 110. Latin America Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 111. Latin America Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. Europe Foot & Mouth Disease Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Europe Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 114. Europe Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 115. Europe Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 116. Europe Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 117. Europe Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 118. Europe Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 119. Europe Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 120. Europe Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 121. Europe Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. Middle East Foot & Mouth Disease Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Middle East Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 124. Middle East Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 125. Middle East Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 126. Middle East Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 127. Middle East Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. Middle East Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 129. Middle East Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 130. Middle East Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 131. Middle East Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. Africa Foot & Mouth Disease Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Africa Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 134. Africa Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 135. Africa Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 136. Africa Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 137. Africa Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. Africa Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. Africa Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 140. Africa Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 141. Africa Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. Global Foot & Mouth Disease Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. ASEAN Foot & Mouth Disease Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. ASEAN Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 145. ASEAN Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 146. ASEAN Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 147. ASEAN Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 148. ASEAN Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. ASEAN Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 150. ASEAN Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 151. ASEAN Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 152. ASEAN Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. GCC Foot & Mouth Disease Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. GCC Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 155. GCC Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 156. GCC Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 157. GCC Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 158. GCC Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 159. GCC Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 160. GCC Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 161. GCC Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 162. GCC Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. European Union Foot & Mouth Disease Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. European Union Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 165. European Union Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 166. European Union Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 167. European Union Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 168. European Union Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. European Union Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 170. European Union Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 171. European Union Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 172. European Union Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. BRICS Foot & Mouth Disease Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. BRICS Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 175. BRICS Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 176. BRICS Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 177. BRICS Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 178. BRICS Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. BRICS Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 180. BRICS Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 181. BRICS Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 182. BRICS Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. G7 Foot & Mouth Disease Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 184. G7 Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 185. G7 Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 186. G7 Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 187. G7 Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 188. G7 Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. G7 Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. G7 Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 191. G7 Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 192. G7 Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. NATO Foot & Mouth Disease Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 194. NATO Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 195. NATO Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 196. NATO Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 197. NATO Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 198. NATO Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. NATO Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 200. NATO Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 201. NATO Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 202. NATO Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Global Foot & Mouth Disease Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 204. United States Foot & Mouth Disease Vaccines Market Size, 2017-2032 (USD Million)
TABLE 205. United States Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 206. United States Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 207. United States Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 208. United States Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 209. United States Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. United States Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 211. United States Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 212. United States Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 213. United States Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Canada Foot & Mouth Disease Vaccines Market Size, 2017-2032 (USD Million)
TABLE 215. Canada Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 216. Canada Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 217. Canada Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 218. Canada Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 219. Canada Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. Canada Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 221. Canada Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 222. Canada Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 223. Canada Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. Mexico Foot & Mouth Disease Vaccines Market Size, 2017-2032 (USD Million)
TABLE 225. Mexico Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 226. Mexico Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 227. Mexico Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 228. Mexico Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 229. Mexico Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. Mexico Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 231. Mexico Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 232. Mexico Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 233. Mexico Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. Brazil Foot & Mouth Disease Vaccines Market Size, 2017-2032 (USD Million)
TABLE 235. Brazil Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 236. Brazil Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 237. Brazil Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 238. Brazil Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 239. Brazil Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. Brazil Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 241. Brazil Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 242. Brazil Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 243. Brazil Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. United Kingdom Foot & Mouth Disease Vaccines Market Size, 2017-2032 (USD Million)
TABLE 245. United Kingdom Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 246. United Kingdom Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 247. United Kingdom Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 248. United Kingdom Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 249. United Kingdom Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 250. United Kingdom Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 251. United Kingdom Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 252. United Kingdom Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 253. United Kingdom Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. Germany Foot & Mouth Disease Vaccines Market Size, 2017-2032 (USD Million)
TABLE 255. Germany Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 256. Germany Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 257. Germany Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 258. Germany Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 259. Germany Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 260. Germany Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 261. Germany Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 262. Germany Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 263. Germany Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 264. France Foot & Mouth Disease Vaccines Market Size, 2017-2032 (USD Million)
TABLE 265. France Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 266. France Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 267. France Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 268. France Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 269. France Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. France Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 271. France Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 272. France Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 273. France Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. Russia Foot & Mouth Disease Vaccines Market Size, 2017-2032 (USD Million)
TABLE 275. Russia Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 276. Russia Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 277. Russia Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 278. Russia Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 279. Russia Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 280. Russia Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 281. Russia Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 282. Russia Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 283. Russia Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. Italy Foot & Mouth Disease Vaccines Market Size, 2017-2032 (USD Million)
TABLE 285. Italy Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 286. Italy Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 287. Italy Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 288. Italy Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 289. Italy Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 290. Italy Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 291. Italy Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 292. Italy Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 293. Italy Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 294. Spain Foot & Mouth Disease Vaccines Market Size, 2017-2032 (USD Million)
TABLE 295. Spain Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 296. Spain Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 297. Spain Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 298. Spain Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 299. Spain Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 300. Spain Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 301. Spain Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 302. Spain Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 303. Spain Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 304. China Foot & Mouth Disease Vaccines Market Size, 2017-2032 (USD Million)
TABLE 305. China Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 306. China Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 307. China Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 308. China Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 309. China Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 310. China Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 311. China Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 312. China Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 313. China Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 314. India Foot & Mouth Disease Vaccines Market Size, 2017-2032 (USD Million)
TABLE 315. India Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 316. India Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 317. India Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 318. India Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 319. India Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 320. India Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 321. India Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 322. India Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 323. India Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 324. Japan Foot & Mouth Disease Vaccines Market Size, 2017-2032 (USD Million)
TABLE 325. Japan Foot & Mouth Disease Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 326. Japan Foot & Mouth Disease Vaccines Market Size, by Conventional Vaccines, 2017-2032 (USD Million)
TABLE 327. Japan Foot & Mouth Disease Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 328. Japan Foot & Mouth Disease Vaccines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 329. Japan Foot & Mouth Disease Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 330. Japan Foot & Mouth Disease Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 331. Japan Foot & Mouth Disease Vaccines Market Size, by Offline, 2017-2032 (USD Million)
TABLE 332. Japan Foot & Mouth Disease Vaccines Market Size, by Online, 2017-2032 (USD Million)
TABLE 333. Japan Foot & Mouth Disease Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 334. Australia Foot & Mouth Disease Vaccines Market S

Companies Mentioned

  • Agrovet Market Animal Health S.A.
  • Bayer AG
  • BIGVET Biotech Co., Ltd.
  • Biogénesis Bagó S.A.
  • Biovet Private Limited
  • Boehringer Ingelheim International GmbH
  • Botswana Vaccine Institute
  • Brilliant Bio Pharma Limited
  • Cavet Bio Co., Ltd.
  • Ceva Santé Animale S.A.
  • China Animal Husbandry Industry Co., Ltd.
  • Godrej Agrovet Limited
  • Hester Biosciences Limited
  • Indian Immunologicals Limited
  • Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
  • Inovet BV
  • Intervac Pvt. Ltd.
  • Jinyu Bio-Technology Co., Ltd.
  • Limor de Colombia S.A.
  • Merck & Co., Inc.
  • Middle East Vaccines Company
  • Phibro Animal Health Corporation
  • Selevac Pty Ltd
  • Shen Lian Biotechnology Co., Ltd.
  • Tecon Biology Co., Ltd.
  • VECOL S.A.
  • VETAL Animal Health Products Inc.
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.49 Billion
Forecasted Market Value ( USD ) by 2032 $ 6.01 Billion
Compound Annual Growth Rate9.3%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Foot and Mouth Disease Vaccine Market Report by Animal Type, Vaccine Type, Distribution Channel, and Region 2026-2034 - Product Image

Foot and Mouth Disease Vaccine Market Report by Animal Type, Vaccine Type, Distribution Channel, and Region 2026-2034

  • Report
  • 140 Pages
  • Global
From
Foot and Mouth Disease Vaccine Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Foot and Mouth Disease Vaccine Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Foot and Mouth Disease Vaccine Market Report 2026 - Product Image

Foot and Mouth Disease Vaccine Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Foot and Mouth Disease Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Foot and Mouth Disease Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Veterinary Vaccines Market - Global Forecast 2026-2032 - Product Image

Veterinary Vaccines Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From

About the Foot and Mouth Disease Vaccines Market

The Foot and Mouth Disease (FMD) Vaccines market is a segment of the Animal Pharmaceuticals industry. FMD is a highly contagious viral disease that affects cloven-hoofed animals, such as cattle, sheep, goats, and pigs. Vaccines are used to protect animals from the disease, and the FMD Vaccines market is composed of companies that produce and distribute these vaccines. Vaccines are typically administered through injection, and may be used to prevent outbreaks or to control existing outbreaks. The FMD Vaccines market is highly competitive, with a number of companies offering a variety of products. Companies in the market include Merck Animal Health, Boehringer Ingelheim, Elanco, Zoetis, and Ceva Sante Animale. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.